Eight UPMC Hillman Cancer Center Members Named Highly Cited Researchers in 2024

Tagged with:

This week, Clarivate™ named their list of Highly Cited Researchers for 2024 — an elite group that demonstrates significant and broad influence in their field of research. Each researcher selected has authored multiple Highly Cited Papers™ which rank in the

Novel Immunotherapy Combo Shows Promise in Melanoma

Tagged with: , , ,

Pre-surgery treatment with the novel drug vidutolimod and the PD-1 checkpoint inhibitor nivolumab led to tumor control in 55% of patients with stage 3 cutaneous melanoma, according to the results of a single-arm phase 2 clinical trial led by the

Nivolumab and Relatlimab Work Together to Treat Advanced Melanoma

Tagged with: ,

The results of a recent clinical trial (NCT03743766) published in Cell might pave the way for significant advances in treating advanced melanoma , a serious form of skin cancer. The study, led by University of Pittsburgh and UPMC Hillman Cancer

Jeremy Rich, MD, MHS, MBA, Announced Interim Director

Tagged with:

We are pleased to share that Jeremy Rich, MD, MHS, MBA, deputy director, UPMC Hillman Cancer Center, has been selected and agreed to serve as interim director, effective Aug. 7, to see us through the transition period with Robert Ferris, MD,

Michelle Williams, PhD, Joins UPMC Hillman Cancer Center

Tagged with:

Please join us in welcoming Michelle Williams, PhD, to UPMC Hillman Cancer Center, effective May 1, 2024. Dr. Williams is Assistant Professor in the Department of Pharmacology and Chemical Biology at the University of Pittsburgh.  Dr. Williams will develop an

Devanjan Sikder, DVM, PhD, Joins UPMC Hillman Cancer Center

Tagged with:

Please join us in welcoming Devanjan “Dev” Sikder, DVM, PhD to UPMC Hillman Cancer Center, effective July 1,  2024. Dr Sikder is Associate Professor in the Department of Medicine, Division of Malignant Hematology/Oncology at the University of Pittsburgh and Director

Jeffrey Brodsky, Yuan Chang, and Patrick Moore Elected to American Academy of Arts and Sciences

Tagged with:

Jeffrey Brodsky, PhD, Yuan Chang, MD, and Patrick Moore, MD, MPH, faculty of UPMC Hillman Cancer Center and professors of the University of Pittsburgh, were announced as members to the American Academy of Arts and Sciences. The Academy is a

Ben Van Houten, PhD, Named AAAS Fellow

Tagged with: ,

Bennett Van Houten, PhD, co-director of the Genome Stability Program at UPMC Hillman Cancer Center, and Richard M. Cyert Professor of Molecular Oncology and professor of pharmacology and chemical biology in the University of Pittsburgh School of Medicine, is among

Norman Wolmark, MD, Receives the Medallion for the Advancement of Surgical Care

Tagged with:

Norman Wolmark, MD, received the Medallion for the Advancement of Surgical Care from the American Surgical Association this month. The American Surgical Association is our nation’s oldest and most prestigious surgical association. Dr. Wolmark has contributed to some of the

Marija Balic, MD, ScD, MBA, Joins UPMC Hillman Cancer Center

Tagged with:

Please join us in welcoming Marija Balic, MD, ScD, MBA to UPMC Hillman Cancer Center, effective March 1, 2024 as professor in the Department of Medicine, Division of Hematology/Oncology at the University of Pittsburgh.  Dr. Balic will provide three half days

Top